Effects of oral care on development of oral mucositis and microorganisms in patients with esophageal cancer

Japanese Journal of Infectious Diseases

Volumn 60, Issue 1, 2007, Pages 23-28

  Yoneda, Saori ^a,c   Imai, Susumu ^b   Hanada, Nobuhiro ^b   Yamazaki, Tsuneyoshi ^a   Senpuku, Hidenobu ^c   Ota, Yojiro ^d   Uematsu, Hiroshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d SHIZUOKA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; NEDAPLATIN; POVIDONE IODINE;

ADULT; AGED; ARTICLE; BACTERIUM MUTANT; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; ESOPHAGUS CANCER; FEMALE; HUMAN; INCIDENCE; LAVAGE; MALE; MONOTHERAPY; MOUTH FLORA; MOUTH HYGIENE; MUCOSA INFLAMMATION; NONHUMAN; OPPORTUNISTIC INFECTION; RISK REDUCTION; STREPTOCOCCUS; TOOTHBRUSH;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; ORAL HYGIENE; POVIDONE-IODINE; STOMATITIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS;

EID: 33947365067     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Roth, J.A. and Putnam, J.B., Jr. (1994): Surgery of cancer of the esophagus. Semin. Oncol., 21, 453-461.
2. Coia, L.R. (1994): Chemoradiation as primary management of esophageal cancer. Semin. Oncol., 21, 483-492.
3. Forastiere, A.A., Orringer, M.B., Perez-Tamayo, C., et al. (1993): Preoperative cbemoradioration followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J. Clin. Oncol., 11, 1118-1123.
4. Herskovic, A., Martz, K., al-Sarraf, M., et al. (1992): Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N. Engl. J. Med., 326, 1593-1598.
5. al-Sarraf, M., Martz, K., Herskovic, A., et al. (1997): Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J. Clin. Oncol., 15, 277-284.
6. Kato, H., Fukuchi, M., Manda, R., et al. (2003): Efficacy and toxicity of nedaplatin and 5-FU with radiation treatment for advanced esophageal carcinomas. Anticancer Res., 23, 3493-3498.
7. Ishikura, S., Nihei, K., Ohtsu, A., et al. (2003): Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J. Clin. Oncol., 21, 2697-2702.
8. Beighton, D. and Carr, A.D, (1994): Oppenheim BA. Identification of viridans streptococci associated with bacteraemia in neutropenic cancer patients. J. Med. Microbiol., 40, 202-204.
9. Reuscher, T.J., Sodeifi, A., Scrivani, S.J., et al. (1998): The impact of mucositis on α-hemolytic streptococcal infections in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer, 82, 2275-2281.
10. Yuen, K.Y., Woo, P.C., Tai, J.W., et al. (2001): Effect of clarithromycin on oral mucositis in bone marrow transplant recipients. Haematologica, 86, 554-555.
11. Dodd, M.J., Larson, P.J., Dibble, S.L., et al. (1996): Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy. Oncol. Nurs. Forum, 23, 921-927.
12. Admietz, I.A., Rahn, R., Bottcher, H.D., et al. (1998): Prophylaxis with povidone-iodine against induction of oral mucositis by radiochemotherapy. Support. Care Cancer, 6, 373-377.
13. Borowski, B., Benhamou, E., Pico, J.L., et al. (1994): Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomised controlled trial comparing two protocols of dental care. Eur. J. Cancer B. Oral Oncol., 30B, 93-97.
14. Thiel, H.J., Fietkau, R. and Sauer, R. (1988): Malnutrition and the role of nutritional support for radiation therapy patients. Recent Results Cancer Res., 108, 205-226.
15. Martin, M.V. and van Saene, H.K. (1992): The role of oral microorganisms in cancer therapy. Curr. Opin. Dent., 2, 81-84.
16. Kollmannsberger, C., Budach, W., Stahl, M., et al. (2005): Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ ARO/ACO. Ann. Oncol., 16, 1326-1333.
17. Bryskier, A. (2002): Viridens group streptococci, a reservoir of resistant bacteria in oral cavities. Clin. Microbiol. Infect., 2, 65-69.
18. Moore, W.E. and Moore, L.V. (1994): The bacteria of periodontal diseases. Periodontol. 2000, 5, 66-77.
19. Kroes, I., Lepp, P.W. and Relman, D.A. (1999): Bacterial diversity within the human subgingival crevice. Proc. Natl. Acad. Sci. USA, 96, 14547-14552.
20. Paster, B.J., Boches, S.K., Galvin, J.L., et al. (2001): Bacterial diversity in human subgingival plaque. J. Bacteriol., 183, 3770-3783.
21. World Health Organization (1986): Oral Health Surveys. Basic Method. World Health Organization, Geneva.
22. Gold, O.G., Jordan, H.V. and Van Houte, J. (1973): A selective medium for Streptococcus mutans. Arch. Oral Biol., 18, 1357-1364.
23. Tsuha, Y., Hanada, N., Asano, T., et al. (2004): Role of peptide antigen for induction of inhibitory antibodies to Streptococcus mutans in human oral cavity. Clin. Exp. Immunol. 137, 393-401.
24. Murray, R.G.E., Brenner, D.J., Bryant, M.R., et al. (1989): Bergey's Manual of Systemic Bacteriology. vol. 1-4. Williams and Wilkins, Baltimore.
25. Salam, M.A., Senpuku, H., Nomura, Y., et al. (2001): Isolation of opportunistic pathogens in dental plaque, saliva and tonsil samples from elderly. Jpn. J. Infect. Dis., 54, 193-195.
26. Senpuku, H., Sogame, A., Inoshita, E., et al. (2003): Systemic diseases in association with microbial species in oral biofilm form elderly requiring care. Gerontology, 49, 301-309.
27. Hall, J.G., Eis, P.S., Law, S.M., et al. (2000): Sensitive detection of DNA polymorphisms by the serial invasive signal amplification reaction. Proc. Natl. Acad. Sci. USA, 97, 8272-8277.
28. Mashima, Y., Nagano, M., Funayama, T., et al. (2004): Rapid quantification of the heteroplasmy of mutant mitochondrial DNAs in Leber's hereditary optic neuropathy using the Invader technology Clin. Biochem., 37, 268-276.
29. Peterson, D.E. and Cariello, A. (2004): Mucosal damage: a major risk factor for sever complications after cytotoxic therapy. Semin. Oncol., 31 (Suppl. 8), 35-44.
30. Moreno, E.C., Kresak, M. and Hay, D.I. (1984): Adsorption of molecules of biological interest onto hydroxyapatite. Calcif. Tissue Int., 36, 48-59.
31. Gibbons, R.J. and Hay, D.I. (1988): Human salivary acidic proline-rich proteins and statherin promote the attachment of Actinomyces viscosus LY7 to apatitic surfaces. Infect. Immun., 56, 439-445.
32. Gibbons, R.J., Hay, D.I., Childs, W.C., III., et al. (1990): Role of cryptic receptors (cryptitopes) in bacterial adhesion to oral surfaces. Arch. Oral Biol., 35, 107S-114S.
33. Gibbons, R.J., Hay, D.I. and Schlesinger, D.H. (1991): Delineation of a segment of adsorbed salivary acidic proline-rich proteins which promotes adhesion of Streptococcus gordonii to apatitic surfaces. Infect. Immun., 59, 2948-2954.
34. Vissink, A., Jansma, J., Spijkervet, F.K.L., et al. (2003): Oral sequelae of head and neck radiotherapy. Crit. Rev. Oral Biol. Med., 14, 199-212.
35. Barnard, J.P. and Stinson, M.W. (1999): Influence of environmental conditions on hydrogen peroxide formation by Streptococcus gordonii. Infect. Immun., 67, 6558-6564.
36. Holmberg, K. and Hallander, H.O. (1973): Production of bactericidal concentrations of hydrogen peroxide by Streptococcus sanguis. Arch. Oral Biol., 18, 423-434.
37. Willcox, M.D. and Drucker, D.B. (1988): Partial characterisation of the inhibitory substances produced by Streptococcus oralis and related species. Microbios, 55, 135-145.
38. Sookkhee, S., Chulasiri, M. and Prachyabrued, W. (2001): Lactic acid bacteria from healthy oral cavity of Thai volunteers: inhibition of oral pathogens. J. Appl. Microbiol., 90, 172-179.
39. Uehara, Y., Kikuch, K., Nakamura, T., et al. (2001): Inhibition of methicillin-resistant Staphylococcus aureus colonization of oral cavities in newborns by viridans group streptococci. Clin. Infect. Dis., 32, 1399-1407.
40. 2 produced by viridans group streptococci may contribute to inhibition of methicillin-resistant Staphylococcus aureus colonization of oral cavities in newborns. Clin. Infect. Dis., 32, 1408-1413.
41. Tada, A., Senpuku, H., Motozawa, Y., et al. (2006): Association between commensal bacteria and opportunistic pathogens in the dental plaque of elderly individuals. Clin. Microbiol. Infect., 12, 776-781.
42. Berkelman, R.L., Holland, B.W. and Anderson, R.L. (1982): Increased bactericidal activity of dilute preparations of povidone-iodine solutions. J. Clin. Microbiol., 15, 635-659.
43. Soderling, E., Ketola, T. and Parviainen, T. (1991): Interference of oral hygiene products with an adhesion-based assay of salivary mutans streptococci. Scand. J. Dent. Res., 99, 113-116.
44. Marsh, P.D. (2003): Plaque as a biofilm: pharmacological principles of drug delivery and action in the sub- and supragingival environment. Oral Dis., 9, 16-22.
45. Takeuchi, H., Senpuku, H., Matin, K., et al. (2000): New dental drug delivery system for removing mutans streptococci from the oral cavity effect on oral micro flora. Jpn. J. Infect. Dis., 53, 211-212.
46. Li, Y.H., Lau, P.C., Lee, J.H., et al. (2001): Natural genetic transformation of Streptococcus mutans growing in biofilms. J. Bacteriol., 183, 897-908.
47. Li, Y.H., Tang, N., Aspiras, M.B., et al. (2002): A quorum-sensing signaling system essential for genetic competence in Streptococcus mutans is involved in biofilm formation. J. Bacteriol., 184, 2699-2708.